Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1795176 Target Snapshot

N-lysine methyltransferase KMT5A · SINGLE PROTEIN · Homo sapiens

174Compounds
99Assays
0Approved Drugs
121.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9NQR1. Use UniProt Q9NQR1 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9NQR1 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats N-lysine methyltransferase KMT5A as ChEMBL target CHEMBL1795176, mapped to UniProt Q9NQR1. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
N-lysine methyltransferase KMT5A
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL1795176
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9NQR1
N-lysine methyltransferase KMT5A
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether N-lysine methyltransferase KMT5A is the right protein anchor across sources, using UniProt Q9NQR1 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelN-lysine methyltransferase KMT5A
UniProt AccessionQ9NQR1
Component TypeProtein
Sequence Length393 aa

N-lysine methyltransferase KMT5A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as N-lysine methyltransferase KMT5A, mapped to UniProt Q9NQR1. Sequence length is 393 aa.

Mapped IDQ9NQR1
Review nameN-lysine methyltransferase KMT5A
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC50110.0
KI3.0
EC505.0
KD3.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3934996 7.3 Ki 50.0 Preclinical
CHEMBL337173 6.68 IC50 210.0 Preclinical
CHEMBL3934996 6.48 IC50 330.0 Preclinical
CHEMBL290904 6.43 IC50 370.0 Preclinical
CHEMBL3414625 6.3 IC50 500.0 Preclinical
CHEMBL580421 6.16 IC50 700.0 Preclinical
CHEMBL4791952 6.09 IC50 804.0 Preclinical
CHEMBL4793474 5.89 Kd 1300.0 Preclinical
CHEMBL4793474 5.72 IC50 1900.0 Preclinical
CHEMBL3318284 5.7 Ki 2000.0 Preclinical
Distribution

pChEMBL Value Distribution

16
5.0
4
5.5
10
6.0
3
6.5
1
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

99
Total Assays
51
Tested Compounds
1
Assay Types
Binding — 99 assays, 51 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 73 7 5.9
assay format 21 39 4.7
cell-based format 5 5 5.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine